Gene editing offers a potential permanent solution for high cholesterol

health.kompas.com (Indonesian)

Scientists are developing a gene-editing drug to permanently lower high cholesterol. A pilot study using CRISPR-Cas9 showed a nearly 50% reduction in LDL cholesterol and a 55% decrease in triglycerides in patients with treatment-resistant high cholesterol. This one-time therapy aims to offer lifelong protection against cardiovascular disease, potentially eliminating the need for daily medication.


With a significance score of 6.1, this news ranks in the top 0.2% of today's 31170 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: